{"id":"NCT00447876","sponsor":"Ipsen","briefTitle":"Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis","officialTitle":"Double-blind, Placebo-controlled, Randomised, Multicentre Study on the Efficacy and Safety of a Single Injection of Botulinum Toxin A (200 Units Dysport®) in the Treatment of Chronic Plantar Fasciitis","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2005-07","primaryCompletion":"2009-01","completion":"2009-04","firstPosted":"2007-03-15","resultsPosted":"2017-06-23","lastUpdate":"2019-11-22"},"enrollment":40,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Plantar Fasciitis"],"interventions":[{"type":"BIOLOGICAL","name":"Botulinum toxin type A","otherNames":["AbobotulinumtoxinA (Dysport®)"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Botulinum type A toxin (Dysport®)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will investigate the hypothesis that the analgesic effect of a single injection of Dysport (200 MU) induces a significant reduction of symptoms in chronic cases of plantar fasciitis.","primaryOutcome":{"measure":"Responders Rate at Week 6 (Pain While Moving)","timeFrame":"Baseline and Week 6","effectByArm":[{"arm":"Dysport ® 200 U","deltaMin":25,"sd":null},{"arm":"Placebo","deltaMin":5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"=0.182"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":6,"countries":["Germany"]},"refs":{"pmids":["22673486"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":20},"commonTop":["Plantar fasciitis","Pain in extremity","Osteoarthritis","Arthropathy","Synovial cyst"]}}